🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07063147
Recruiting Observational

TTE Improves Clinical Management of Stable Chest Pain

NCT07063147 · tracked via the Priya Life Science China tracker
Sponsor
Tianjin Chest Hospital
Phase
Observational
Started
2025-01-01
Last updated
2025-07-18

Condition(s) studied

Transthorcic EchocardiographyStable Angina PectorisCoronary Artery DiseaseMajor Adverse Cardiac EventsInvasive Coronary Angiography

Investigational drug(s) / intervention(s)

TTE

TTE: All patients underwent TTE according to established guidelines and local institutional protocols. The imaging data were evaluated using different image post-processing software to comprehensively analyse anatomical, functional and histological information of coronary.

Study summary

The investigator aims to prospectively enroll patients who were referred for transthorcic echocardiography (TTE) for the assessment of stable chest pain (SCP) suspected of obstructive coronary artery disease (CAD). All patients underwent TTE according to established guidelines and local institutional protocols. This study will determine if TTE-based imaging evaluation can provide more informaton to improve clinical management for SCP, including fewer MACE and better decision-making of downstream investigations and therapeutic interventions.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * symptomatic patients with SCP suspected of obstructive CAD. * referred for TTE for the assessment of SCP. * ≥18 years of age. * signed informed consent. Exclusion Criteria: * acute coronary syndromes * previous CAD or coronary revascularization * nonsinus rhythm * cardiomyopathy, valvular disease, congenital heart disease or left cardiac insufficiency because of other reasons

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Tianjin Chest Hospital Tianjin China Recruiting

More Tianjin Chest Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07063147 on ClinicalTrials.gov ↗ ← All trials in China